Health Compass Therapeutics Announces Publication of Phase 2/3 COMPANION-002 Results for Tovecimig in the Journal of Clinical Oncology and Oral Presentation at ESMO 2026 October 24, 2026
Health Celcuity Presents Updated Results from the PIK3CA MT Cohort of the Phase 3 VIKTORIA-1 Study in Patients with HR+/HER2- Advanced Breast Cancer at the ESMO Congress 2026 October 24, 2026
Biotech Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting Antibody-Drug Conjugate ZW191 at ESMO Congress 2026 October 24, 2026
Biotech Immatics Presents Clinical Activity of IMA402 PRAME Bispecific and IMA203CD8 PRAME Cell Therapy across Advanced Solid Tumors in Two Oral Presentations at 2026 ESMO Annual Meeting October 24, 2026
Financial Oxford Square Capital Corp. Schedules Third Quarter 2026 Earnings Release and Conference Call for October 30, 2026 October 24, 2026
Real Estate Elme Communities Announces Suspended NYSE Trading; Anticipates Trading Will Begin OTC Effective October 26, 2026 October 24, 2026
Food & Beverage Black Rock Coffee Bar Continues Expansion in California with New Rancho Cucamonga Location October 24, 2026
Search
pr
October 24, 2026
October 24, 2026
October 24, 2026
October 24, 2026
October 24, 2026
October 24, 2026
October 24, 2026
October 24, 2026
October 24, 2026
October 24, 2026
